Understanding heart disease risk is vital for patients and doctors. This research looks at a specific measurement called left atrial strain, or LAS. It helps doctors see how the heart's upper chamber stretches and relaxes. This study combines data from many sources to see if LAS can warn about future problems. The goal was to find if this sign predicts serious issues like death or hospital stays for heart failure. This matters because heart disease affects millions of people worldwide. Early warning signs can help doctors plan better care and treatment strategies sooner. The researchers wanted to know if LAS works across different types of heart problems and different levels of heart pumping strength. They looked at patients with heart failure, ischemic heart disease, valvular heart disease, and left ventricular hypertrophy. The group included over 13,000 people in total. This large number gives the results more weight than smaller studies might provide. The main result was a combination of death from any cause and hospitalizations for heart failure. The study found that LAS was linked to these major events in most groups. For patients with heart failure, the link was strong. For those with ischemic heart disease, the link was also clear. For patients with valvular heart disease, the connection remained significant. However, for those with left ventricular hypertrophy, the link was not strong enough to be considered a reliable predictor. The numbers showed a relationship between the strain measurement and the risk of events. The researchers noted that this is an association, not a cause. This means LAS does not cause heart events but signals a higher risk. Safety data were not reported in this analysis. The study did not track side effects or how patients felt about the measurement. This is common in studies that focus on prediction rather than treatment. The researchers caution that this is a single analysis of existing data. More research is needed to confirm these findings in new patient groups. Doctors should not change their practice based on this one study alone. The results suggest LAS is a useful tool for risk assessment in many heart conditions. It works across different types of heart failure and other diseases. Patients should talk to their doctors about what these measurements mean for their specific situation. Understanding risk factors helps in managing heart health over the long term. This research adds to the growing list of tools doctors use to guide care.
Left Atrial Strain predicts major cardiovascular events with HR 0.91 in general populationLeft Atrial Strain Predicts Heart Events in Patients With Heart Disease
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This systematic review and meta-analysis synthesized evidence on Left Atrial Strain (LAS) as a predictor of cardiovascular outcomes. The analysis included a total sample size of 13,156 participants from the general population and patients with specific cardiovascular diseases. The setting was not reported. The intervention or exposure was the measurement of Left Atrial Strain. No specific comparator was reported. The primary outcome was a composite of all-cause death and heart failure hospitalizations, though specific results for this composite were not detailed in the provided data. The main results focused on major cardiovascular events as a key outcome.
The primary analysis for major cardiovascular events in the general population showed that LAS was a significant predictor. The effect size was a hazard ratio (HR) of 0.91, with a 95% confidence interval (CI) of 0.86 to 0.96. This indicates a predictive association where higher LAS values are associated with a lower risk of events. In patients with heart failure (HF), LAS also predicted major cardiovascular events with an HR of 0.93 (95% CI 0.89 to 0.97). For patients with ischemic heart disease (IHD), the HR was 0.95 (95% CI 0.91 to 0.99). In patients with valvular heart disease (VHD), the HR was 0.94 (95% CI 0.90 to 0.97). In contrast, for patients with left ventricular hypertrophy (LVH), LAS did not significantly predict major cardiovascular events, with an HR of 0.98 (95% CI 0.84 to 1.15).
Key secondary outcomes were not reported in the provided data. Safety and tolerability findings were also not reported; adverse events, serious adverse events, discontinuations, and overall tolerability were all noted as not reported. This represents a significant gap in the evidence regarding the safety profile of measuring LAS.
These results can be compared to prior landmark studies in cardiovascular imaging and prognostication. While specific prior studies are not named in the input, the consistent predictive association across multiple disease states aligns with the growing body of evidence supporting strain imaging in heart failure and other cardiomyopathies. The finding that LAS was not predictive in LVH is a notable divergence that may inform future research priorities.
Key methodological limitations include the lack of reported setting, follow-up duration, and specific details on the primary composite outcome. The analysis is observational in nature, and the causality note explicitly states the findings are an association, not causation. The certainty of the evidence was not reported. Potential biases cannot be assessed due to the lack of detailed methodology in the input.
The clinical implications are that LAS represents a powerful predictor of major cardiovascular events in the general population and in patients with different cardiovascular diseases across left ventricular ejection fraction (LVEF) ranges, as noted in the practice relevance. This suggests LAS could be integrated into risk stratification models. However, clinicians must recognize this is a prognostic marker, and its measurement should not replace established clinical assessments.
Unanswered questions remain. The specific protocol for LAS measurement, the optimal cutoff values for risk prediction, and the clinical utility of guiding therapy based on LAS are not defined. The long-term impact of using LAS in routine practice is unknown. Future research should address these gaps, including prospective trials to test if acting on LAS measurements improves patient outcomes.
More on Heart Failure
View Original Abstract ↓
Machine Learning Model Performance for Predicting Contrast Induced Nephropathy in Coronary Interventions
Machine learning models help predict kidney damage during heart procedures
Related in Radiology & Imaging
From Other Specialties
